Patent · US Active

Designed ankyrin repeat domains with altered surface residues

US11578427B2 · kind B2 · utility

1Cited by
12References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2021
Grant dateFeb 14, 2023
Priority date
Expiry dateAug 12, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to designed ankyrin repeat domains with altered surface residues, as well as to proteins comprising such a designed ankyrin repeat domain, nucleic acids encoding such domains or proteins, methods of preparing such proteins, pharmaceutical compositions comprising such proteins or nucleic acids, and the use of such proteins, nucleic acids or pharmaceutical compositions in the treatment of diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.